(Q24798487)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Antipsychotic-induced weight gain: a comprehensive research synthesis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

The positive and negative syndrome scale (PANSS) for schizophrenia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

A New Depression Scale Designed to be Sensitive to Change

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Body weight, image and self-esteem evaluation questionnaire: development and validation of a new scale.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Practice guideline for the treatment of patients with schizophrenia, second edition.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

A systematic review of atypical antipsychotic drugs in schizophrenia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Perceptions of body image among working men and women.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

The clinical implications of weight gain in schizophrenia.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Antipsychotic-associated weight gain and clinical outcome parameters

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Atypical antipsychotics and weight gain--a systematic review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Physical and psychological consequences of weight gain

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Novel antipsychotics: comparison of weight gain liabilities.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Weight control behaviors among adult men and women: cause for concern?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

"Specific" scale compared with "generic" scale: a double measurement of the quality of life in a French community sample of obese subjects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Weight gain among schizophrenic patients treated with clozapine

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Differential effect of clozapine on weight: a controlled study

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Weight as a Correlate of Clinical Response to Psychotropic Drugs

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Clozapine-induced weight gain: prevalence and clinical relevance

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Change in body weight and longevity

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Discovering the neural basis of human social anxiety: a diagnostic and therapeutic imperative

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

Olanzapine: weight gain and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

Weight gain among patients on clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

Clozapine-induced weight gain predicts improvement in psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

Antipsychotic-induced weight gain and therapeutic response: a differential association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

Olanzapine versus risperidone: weight gain and elevation of serum triglyceride levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

Gender differences in chronic major and double depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

Depression in schizophrenia: recognition and management in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

The impact of weight gain on quality of life among persons with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

Weight gain and quality of life among patients taking antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

Body mass index and quality of life in community-dwelling patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

Low cerebellar metabolism in medicated patients with chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

Current obesity, steady weight change and weight fluctuation as predictors of physical functioning in middle aged office workers:the Whitehall II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-5-3

Weight changes in relation to the characteristics of patients on chlorpromazine

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Effects of Patient Demographics, Risperidone Dosage, and Clinical Outcome on Body Weight in Acutely Exacerbated Schizophrenia

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Weight gain induced by clozapine

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

Clozapine and weight gain.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=547901

The association between weight change and psychological well-being in women

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15649317

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Weight changes during treatment with phenothiazine derivatives

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15649317

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/15649317